BioMarin Pharmaceuticals
BMRN
BMRN
552 hedge funds and large institutions have $15.6B invested in BioMarin Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 102 funds opening new positions, 186 increasing their positions, 175 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
9% more funds holding
Funds holding: 507 → 552 (+45)
6% more repeat investments, than reductions
Existing positions increased: 186 | Existing positions reduced: 175
0.5% more ownership
Funds ownership: 95.99% → 96.48% (+0.5%)
Holders
552
Holding in Top 10
8
Calls
$157M
Puts
$137M
Top Buyers
| 1 | +$254M | |
| 2 | +$130M | |
| 3 | +$116M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$104M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
+$81.7M |
Top Sellers
| 1 | -$439M | |
| 2 | -$144M | |
| 3 | -$125M | |
| 4 |
Goldman Sachs
New York
|
-$59.3M |
| 5 |
DLPIC
Davide Leone & Partners Investment Company
London,
United Kingdom
|
-$55.3M |